Skip to Content

Tools

Activity

Planning for the Evaluation of Global HIV/AIDS Programs

Type:
Consensus Study
Topic(s):
Diseases, Global Health, Children and Families
Board(s):
Board on Children, Youth, and Families, Board on Global Health

Activity Description

The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), launched in 2003 to combat global HIV/AIDS, comprised a five-year, $15 billion commitment to provide antiretroviral therapies to 2 million individuals, prevent seven million new HIV infections, and care for 10 million people, including orphans and other children made vulnerable by HIV/AIDS. This legislation represented the largest commitment by any nation to combat a single disease in history and the largest international public health program ever undertaken by the United States.

The law was reauthorized in 2008 under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act. The bill extended the program for five additional years, through 2013, and authorized up to $48 billion for PEPFAR bilateral HIV/AIDS programs and U.S. contributions to the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria.

The IOM Committee on Planning the Assessment/Evaluation of HIV/AIDS Programs Implemented Under the US Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 will develop a plan for a congressionally mandated evaluation of HIV/AIDS programs implemented under the recent reauthorization legislation. The plan for the evaluation will take into account the need to assess the following aspects of these programs: 

  • Progress toward prevention, treatment, and care targets
  • Effects on health systems
  • Efforts to address gender-specific aspects of HIV/AIDS
  • Impact of programs on child mortality
  • Impact of interventions on behalf of orphans and vulnerable children
The committee will issue a short report to the U.S. Congress on the plan's proposed design and budget in 2010.

For more information